Physician profile
Thomas L Weeks
NPI 1760427090
$906.52
in general payments reported to CMS, 2019-2025
17 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.18 · 2020: $62.47 · 2021: $147 · 2022: $26.81 · 2023: $382 · 2024: $57.07 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $591.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $183.53 | 2019-2023 | Liletta |
| Myriad Women'S Health, INC. | $145.87 | 2023 | Myrisk |
| Hologic Sales and Service, LLC | $80.45 | 2019-2025 | Novasure, Myosure Tissue Removal Device, Acessa Provu System |
| Pfizer INC. | $74.88 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $63.09 | 2025 | |
| Astellas Pharma US INC | $59.54 | 2023-2025 | Veozah |
| Shield Therapeutics INC | $47.79 | 2023-2024 | Accrufer |
| Organon LLC | $43.91 | 2021-2023 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $43.68 | 2020-2024 | |
| Merck Sharp & Dohme LLC | $32.11 | 2020-2021 | |
| Amag Pharmaceuticals, INC. | $30.49 | 2019 | |
| Kci USA, INC. | $24.07 | 2023 | Prevena |
| Baxter Healthcare | $20.57 | 2023 | Tisseel |
| Solventum Corporation | $17.54 | 2025 | Prevena |
| Smith+Nephew, INC. | $15.13 | 2023 | Pico 7 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $12.11 | 2021 | |
| Avion Pharmaceuticals | $11.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Weeks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.